Minnesota Resource Allocation Platform for COVID-19 Treatment
The Minnesota Resource Allocation Platform is an online tool that connects patients and health care providers with COVID-19 medications that are in limited supply. The platform also helps to distribute these medications in an equitable way when there is not enough for everyone who needs them.
COVID-19 patients, their caregivers, or their health care providers can use the MN Resource Allocation Platform to find out which medications are available, whether they will help the person with COVID-19, and whether the person is able to get medication.
If someone can get a COVID-19 medication, the MN Resource Allocation Platform passes along information on their behalf to a health care facility that can give it. A final decision about whether someone can get a medication is up to the health care provider at that facility.
How it works
The platform uses a lottery system when supplies are limited. The system gives every patient who could get medication a chance at getting their information passed along to a health care provider that gives the drug. Health care providers make the final decision about whether these patients are able to get the drug.
Priority is given to long-term care residents and essential workers at high risk for exposure to COVID-19, such as health care workers or teachers. These groups come first due to their higher risk of severe illness and death (long-term care residents) and our need for essential workers to be able to keep doing their jobs to provide services that our communities need.
During times when there are enough drugs to go around, information from every patient who could get a drug is passed along to health care providers that give the drug treatments.
If there are not enough appointments to go around, but a patient would be able to get a medication if they could get an appointment, the platform automatically enters the patient into a drawing for a second chance to get treatment with medications left over from that day. If they are not picked during the second lottery, they are no longer able to get the medication and they are not able to apply again.
To get these medications, you must have COVID-19 symptoms and proof of a positive COVID-19 test (saliva or nasal swab). You also need to fill out the MN Resource Allocation Platform Screening Form to see if you may be able to get one of the medications.
This online form will ask about your age, medical history, the type of work you do, whether you have COVID-19 symptoms, and contact information where a health care worker can reach you.
While you do not have to answer the questions, the more questions you answer the better job the system can do deciding if you may be able to get a medication. Your answers are private.
When you finish filling out the form, you will be notified right away about whether you may be able to get a medication, and about next steps. You will also be sent an email with this information.
The platform does not make the final decision about who can get a medication. It only decides who may be able to get it. The final decision is up to the health care provider at the facility that gives these types of medications.
The MN Resource Allocation Platform is currently for adult patients only. Children aged between 12 and 17 may also qualify for a monoclonal antibody treatment, but will need to work directly with their provider to determine whether they are eligible instead of submitting information on this platform.
If you have questions about other types of COVID-19 treatments, read Therapeutic Options for COVID-19 Patients.
More information on treatment options
- Monoclonal Antibody Treatment: Frequently Asked Question
- Bamlanivimab: Fact sheet for Patients, Parents and Caregivers
- Casirivimab/Imdevimab: Fact Sheet for Patients, Parents and Caregivers
- Therapeutic Options for COVID-19 Patients
Monoclonal antibody treatments are available through the Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for non-hospitalized COVID-19 positive people.
For more information on these treatments, ethical guidance, and eligibility, visit Monoclonal Antibody (mAb) Treatment.
Please note: providers submitting data on behalf of the patient are responsible for their own compliance with any health privacy laws or regulations that apply to them.
MN Resource Allocation Platform screening process
- Read Monoclonal Antibody Treatment: Frequently Asked Questions.
- Review the Emergency Use Authorization (EUA) information for these drug treatments.
Drug treatments available through MNRAP are authorized by the FDA under an EUA, meaning they have not been fully FDA-approved. In an emergency, like a pandemic, it may not be possible to have all the evidence that the FDA would usually have before approving a treatment. In this situation, the FDA can make a judgment to release drug treatments for use before it's fully approved. If there's evidence that strongly suggests that patients have benefited from a treatment, the agency can issue an EUA to make it available. An EUA does not mean that a treatment has not been studied, or that a treatment is experimental. Receiving a drug under an EUA is different than participating in a clinical trial.
If you are referred for a treatment, you will be given additional information about the treatment at your appointment. You will also be asked whether you consent to receive the treatment. You may choose to opt out at any time. If you are unsure about whether you should receive one of these treatments, please speak to your health care provider and read through the patient fact sheets for more information.
Keep in mind that the two monoclonal antibody treatments currently available through MNRAP have the same eligibility criteria. Which one you receive will be up to the health care facility where your referral is sent. As more treatment options become available, patients may be referred for specific treatments depending on which one they are most likely to benefit from.
Read more about Emergency Use Authorizations.
- Review this information about the data you submit using this screening form.
Your answers are private and cannot be shared with employers or any other authorities without your consent, except as allowed by law. The Minnesota Department of Health will have access to your answers for the purposes of administering the Minnesota Resource Allocation Platform and understanding the demand for this medication. Additionally, if you qualify for this medication, your information may be shared with the health care providers in Minnesota that are involved in providing this medication. You are not legally required to answer the questions in this form. If you choose not to answer the questions, the system may not be able to determine whether you are clinically eligible for this medication and cannot provide your information to a health care provider that gives the medication.
- Fill out the MN Resource Allocation Platform screening form. The screening form takes approximately 10-15 minutes to complete. Before completing the screening form, please have with you:
- Medical records
- Prescription records
- Contact information ready: address, phone number, email